Novavax's Earnings Outlook
Portfolio Pulse from Benzinga Insights
Novavax (NASDAQ:NVAX) is scheduled to release its quarterly earnings report on February 28, 2024, with analysts expecting an EPS of $-0.50. Despite past earnings beats, Novavax's stock price has experienced declines following earnings announcements. Shares are currently trading at $5.5, down 16.18% over the last year. Investors are looking for positive guidance for the next quarter.
February 27, 2024 | 6:01 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Novavax is expected to report an EPS of $-0.50 for the upcoming quarter. Historical data shows stock price declines following earnings announcements, despite past earnings beats. Shares have decreased by 16.18% over the last year.
Given Novavax's history of stock price declines following earnings announcements, even after beating EPS estimates, and the overall negative performance over the past year, it's likely that the stock may experience short-term negative impact. The anticipation of the earnings report, coupled with the expectation of a negative EPS and the historical trend of stock price decreases post-earnings, supports a negative outlook.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100